Cite

HARVARD Citation

    Baker, E. et al. (2021). Insights from compassionate use of tocilizumab for COVID‐19 to inform appropriate design of randomised controlled trials. British journal of clinical pharmacology. 87 (3), pp. 1584-1586. [Online]. 
  
Back to record